Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, LICENSEE shall ▇▇▇▇, and shall cause its Sublicensees to undertake to ▇▇▇▇, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.
Appears in 2 contracts
Sources: Exclusive License Agreement (Acer Therapeutics Inc.), Exclusive License Agreement (Opexa Therapeutics, Inc.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, LICENSEE shall ▇▇▇▇, and shall cause its Sublicensees to undertake to ▇▇▇▇, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.
Appears in 2 contracts
Sources: Exclusive License Agreement (Allovir, Inc.), Exclusive License Agreement (Allovir, Inc.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, LICENSEE shall ▇▇▇▇mark, and shall cause its Sublicensees sublicensees to undertake to ▇▇▇▇mark, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.
Appears in 2 contracts
Sources: Exclusive License Agreement (Cara Therapeutics, Inc.), Exclusive License Agreement (Cara Therapeutics, Inc.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, LICENSEE the Licensee shall ▇▇▇▇, and shall cause its Sublicensees to undertake to ▇▇▇▇, ▇ all Licensed Products that are manufactured or sold under this Agreement in accordance with the number of each issued applicable patent under the Patent Rights that applies to such Licensed Productmarking laws.
Appears in 1 contract
Marking of Licensed Products. To the extent required by Applicable Law, commercially feasible and consistent with prevailing business practices, LICENSEE shall ▇m▇▇▇, and shall cause require its Sublicensees to undertake to ▇m▇▇▇, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.
Appears in 1 contract
Sources: Exclusive License Agreement (Marker Therapeutics, Inc.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, LICENSEE shall ▇▇▇▇mark, and shall cause its Sublicensees to undertake to ▇▇▇▇mark, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.
Appears in 1 contract
Sources: Exclusive License Agreement (Fate Therapeutics Inc)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, LICENSEE the Licensee shall ▇▇▇▇, ▇ and shall cause its Affiliates and Sublicensees to undertake to ▇▇▇▇, ▇ all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights Licensed Patents that applies to such a Licensed Product.
Appears in 1 contract
Sources: Evaluation License and Option Agreement (BioLineRx Ltd.)